Team

The Baermed Group unites leading companies in the fields of tissue engineering, regenerative medicine, AI-supported software solutions and specialized surgical consulting:

  • Baermed Tissue Engineering AG – Pioneer in the development of biomedical solutions, specializing in cell therapies and innovative tissue constructs for mini organ implantations
  • Tarumanagara Human Cell Technology Laboratory (Jakarta) – Highly specialized research center for cell matrix technologies and regenerative therapies.
  • AI Solutions department – Development of state-of-the-art AI-supported software for business applications.
  • Baermed Abdominal Medicine – Cooperation with research projects

The group is led by:

Hans U. Baer, MD
Associate Professor of Surgery, University of Bern
Guest Professor, Universitas Tarumanagara Jakarta
General Surgery,| Gastrointestinal Surgery
Master of Applied Ethics

With interdisciplinary expertise, we are driving the future of medicine, mini organ development and digitalization with artificial intelligence (AI).

BAERMED TISSUE ENGINEERING AG

Prof. Dr. med. Hans U. Baer

Prof. Dr. med. Hans U. Baer
Specialist in surgery and visceral surgery, Master of Applied Ethics

Chairman of the Board of Directors

hans.baer@baermed.ch

More about Prof. Dr. med. Hans U. Baer

Download Curriculum Vitae

Profile

  • Prof. titularis University of Bern
  • Prof. Universitas Tarumanagara, Jakarta, Indonesia (visiting)
  • Dr. med. University of Zurich
  • Specialist for surgery, especially: visceral surgery
  • Master of Applied Ethics (MAE) University of Zurich
  • International Director of the Tarumanagara Human Cell Technology Laboratory (THCT Lab).
  • Managing Director of Medicalculis GmbH in Zurich
  • Honorary President of Health Care and life and Member of the Global Advisory Board of Swiss Strategic Partners (SSP)
  • Colonel (ret.) of the Swiss Army Medical Corps and Kdt (ret.) of the ICMM Course LOAC
  • Languages: German, English, French, (Italian)

Activity

Prof. Dr. med. Hans U. Baer…

  • is accredited at the Hirslanden Clinic in Zurich.
  • runs a practice for abdominal medicine and visceral surgery at the Hirslanden Clinic, Zurich.
  • works closely with the Zurich Surgical Center (CZZ).
  • undertakes consultations, clarifications, second opinions and expert opinions in complex and oncological abdominal surgery and tumor surgery.
  • is Honorary President of Health Care of the Strategic Swiss Partner AG
  • leads the Tarumanagara Human Cell Technology Laboratory (THCT Lab) at Tarumanagara University (UNTAR) in Jakarta, Indonesia as International Director

Core competencies

Prof. Dr. med. Hans U. Baer has expertise in complex abdominal surgery and tumor surgery, clarification, diagnosis, consultation, treatment suggestions and second opinion in the fields of open and laparoscopic surgery of:

  • Liver
  • Pancreas (pancreas)
  • Gall bladder, bile ducts
  • Large intestine, small intestine, rectum
  • Hernias (soft tissue hernia) of the groin and abdominal wall
  • Obesity

Research activity in the field of visceral surgical tissue engineering.

Prof. Dr. med. Hans U. Baer conducts basic and clinical research for cell matrix implants and mini-organs in collaboration with Tarumanagara Human Cell Technology Laboratory (THCT Lab), a research laboratory at Tarumanagara University (UNTAR), Jakarta, Indonesia, as well as with the private hospital Rumah Sakit Gading Pluit and the Liver Clinic, both institutes in Jakarta, Indonesia.

HEPADUA® Mini Liver

Liver cell matrix implant is a newly developed treatment method for severe chronic liver cirrhosis. Currently, the “HEPADUA® Mini-Liver Implant” is undergoing clinical trials.


Dr. med. Christina Baer-Suryadinata

Dr. med. Christina Baer-Suryadinata
Member of the Board of Directors
Head of Finance

christina.baer@baermed.ch


Hans X. Baer

Hans X. Baer
Member of the Board of Directors

Luxury Sales Representative Diageo for Stuttgart & Greater Area, Germany


Meiling M. Baer

Meiling M. Baer
Member of the Board of Directors

Operational Supervisor Cartier, St. Moritz, Switzerland

Research team

Research team of the Baermed Group

Baermed research focuses on innovative approaches in regenerative medicine, cell implantation, the production of mini organs and artificial intelligence.

Our research center, the Tarumanagara Human Cell Technology Laboratory (THCT Lab) at Tarumanagara University (UNTAR) in Jakarta, Indonesia, is dedicated to basic and clinical research in the field of tissue engineering, cell matrix implants and mini organs. The current focus is on:

  • HEPADUA® Mini-Liver Implant – Development and clinical studies on bioartificial liver implants to support liver function.
  • Conditioned medium and secretome therapy – investigation and production of the body’s own secretomes from stem cells to promote cell regeneration. And new therapies for a variety of diseases.

Another central area of research is conducted by the AI Solutions department, which develops artificial intelligence for business applications using its own research infrastructure. The focus here is on innovative solutions for analyzing data, automating processes and digital transformation in the healthcare sector.

Our research combines cutting-edge biotechnology with AI-supported innovation to actively shape the future of medicine.

Prof. Dr. med. Hans U. Baer

Prof. Dr. med. Hans U. Baer
International Director of the Tarumanagara Human Cell Technology Laboratory (THCT Lab).

hans.baer@baermed.ch

More about Prof. Dr. med. Hans U. Baer

Download Curriculum Vitae

Profile

  • Prof. titularis University of Bern
  • Prof. Universitas Tarumanagara, Jakarta, Indonesia (visiting)
  • Dr. med. University of Zurich
  • Specialist for surgery, especially: visceral surgery
  • Master of Applied Ethics (MAE) University of Zurich
  • International Director of the Tarumanagara Human Cell Technology Laboratory Research Laboratory.
  • Managing Director of Medicalculis GmbH in Zurich.
  • Honorary President of Health Care and life and Member of the Global Advisory Board of Swiss Strategic Partners (SSP).
  • Colonel (ret.) of the Swiss Army Medical Corps and Kdt (ret.) of the ICMM Course LOAC
  • Languages: German, English, French, (Italian)

Activity

Prof. Dr. med. Hans U. Baer…

  • is accredited at the Hirslanden Clinic in Zurich.
  • runs a practice for abdominal medicine and visceral surgery at the Hirslanden Clinic Zurich.
  • works closely with the Zurich Surgical Center (CZZ).
  • undertakes consultations, clarifications, second opinions and expert opinions in complex and oncological abdominal surgery and tumor surgery.
  • is Honorary President of Health Care of the Strategic Swiss Partner AG
  • leads the Tarumanagara Human Cell Technology Laboratory (THCT Lab) at Tarumanagara University (UNTAR) in Jakarta, Indonesia as International Director

Core competencies

Prof. Dr. med. Hans U. Baer has expertise in complex abdominal surgery and tumor surgery, clarification, diagnosis, consultation, treatment suggestions and second opinion in the fields of open and laparoscopic surgery of:

  • Liver
  • Pancreas (pancreas)
  • Gall bladder, bile ducts
  • Large intestine, small intestine, rectum
  • Hernias (soft tissue hernia) of the groin and abdominal wall
  • Obesity

Research activity in the field of visceral surgical tissue engineering.

Prof. Dr. med. Hans U. Baer, conducts basic and clinical research for cell matrix implants and mini-organs in collaboration with Tarumanagara Human Cell Technology Laboratory (THCT Lab), a research laboratory of Tarumanagara University (UNTAR), Jakarta, Indonesia as well as Private Hospital Rumah Sakit Gading Pluit, Jakarta, Indonesia and Liver Clinic, Jakarta, Indonesia.

HEPADUA® Mini-Liver Implant

Liver cell matrix implant is a newly developed treatment method for severe chronic liver cirrhosis. The “HEPADUA® Mini-Liver Implant” is currently undergoing a clinical trial.

Tarumanagara Human Cell Technologies Lab (THCT Lab)

Our basic research team works in the state-of-the-art THCT Lab at the University of Tarumanagara (UNTAR) in Jakarta, Indonesia. Here we conduct groundbreaking research in the field of human cell technologies.

Eduard Tjahjadi

Eduard Tjahjadi
Dipl. Ing.

Supervisory Board Tarumanagara Foundation

eduard.tjahjadi8@gmail.com

Assoc. Prof. Siufui Hendrawan, MD, PhD

Assoc. Prof. Siufui Hendrawan, MD, PhD
M. Biomed

Head of Tarumanagara Human Cell Technology Laboratory (THCT Lab) and
Senior Researcher of Faculty of Medicine, Tarumanagara University (UNTAR)

siufui@gmail.com

Download Curriculum Vitae

Jennifer Lheman

Jennifer Lheman
B.Sc, M.Biotek

Senior Researcher of Tarumanagara Human Cell Technology Laboratory (THCT Lab)

jenlheman@hotmail.com

Nuraeni

Nuraeni
B.Sc

Researcher of Tarumanagara Human Cell Technology Laboratory (THCT Lab)

e.nuraeni22@yahoo.com

Olivia Marcelina

Olivia Marcelina
B.Sc, M.Eng

Researcher of Tarumanagara Human Cell Technology Laboratory (THCT Lab)

olivia.marcelina@gmail.com

Erwin Uliyantoro

Erwin Uliyantoro

Facility Manager and Head of Animal Care of Tarumanagara Human Cell Technology Laboratory (THCT Lab)

erwinulil80@gmail.com

Renantha

Renantha
B.E

Secretary of Tarumanagara Human Cell Technology Laboratory (THTC Lab)

renantha04@gmail.com

Research and clinical studies

The Tarumanagara Human Cell Technologies Laboratory (THCT Lab) at the University of Tarumanagara (UNTAR) in Jakarta, Indonesia, is the center of our basic research. Clinical implementation was carried out in close collaboration with two specialized institutions:

The Rumah Sakit Gading Pluit Hospital took over the surgical procedures, including:

  • Liver tissue sampling
  • Mini-liver implants
  • Clinical monitoring of patients

The Hati Clinic (liver clinic) was an essential partner over the entire study period of eight years and was responsible for:

  • Development of the study protocols
  • Patient selection
  • Postoperative controls
  • Monitoring of phase I and phase II studies

These extensive clinical studies were carefully conducted and documented over a period of eight years.

Research and clinical studies

Further phase I and phase II studies are currently being conducted in Jakarta, focusing on the use of conditioned medium for various diseases.

Dr. dr. Barlian Sutedja, Sp. B.

Dr. dr. Barlian Sutedja, Sp. B.
Abdominal Surgeon, President and Director

dr.barlian@pluit-hospital.com

Dr. Peter Limas, Sp. B.

Dr. Peter Limas, Sp. B.
Abdominal Surgeon

pi_limas@yahoo.com

Prof. Ronokusumo Sjamsuhidajat MD

Prof. Ronokusumo Sjamsuhidajat MD
Chairman of Local Ethics Committee

sronokusumo@yahoo.com.sg

Dr. dr. Andri Sanityoso SpPD KGEH

Dr. dr. Andri Sanityoso SpPD KGEH
Hati Clinic Prof. Ali Sulaiman
Hepatologist

andri_sani@yahoo.com